2024-20999. Medical Devices; Therapeutic Devices; Classification of the Pediatric Continuous Renal Replacement Therapy System  

  • Table 1—Pediatric Continuous Renal Replacement Therapy System Risks and Mitigation Measures

    Identified risks to health Mitigation measures
    Adverse tissue reaction Biocompatibility evaluation, Pyrogenicity testing, and Non-clinical performance testing.
    Death Labeling, Clinical performance testing, and Usability testing.
    Infection Labeling, Reprocessing validation, Pyrogenicity testing, Shelf life testing, and Usability testing.
    Inadequate or incomplete treatment Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software verification, validation, and hazard analysis.
    Clearance of essential blood substances or medications Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software verification, validation, and hazard analysis.
    Blood loss or blood cell destruction Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; and Software verification, validation, and hazard analysis.
    Thermal injury Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software verification, validation, and hazard analysis.
    Blood leak into the dialysis fluid Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; and Software verification, validation, and hazard analysis.
    Fluid imbalance Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; and Software verification, validation, and hazard analysis.
    Air embolism Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software verification, validation, and hazard analysis.
    Fluid pump(s) reversal resulting in air infusion via the arterial bloodline Non-clinical performance testing; Clinical performance testing; Labeling; Shelf-life testing; Usability testing; and Software, verification, validation, and hazard analysis.
    Electrical shock Electrical safety testing.
    Electromagnetic interference with other devices/equipment Electromagnetic compatibility (EMC) testing.

Document Information

Effective Date:
9/16/2024
Published:
09/16/2024
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final amendment; final order.
Document Number:
2024-20999
Dates:
This order is effective September 16, 2024. The classification was applicable on April 29, 2020.
Pages:
75493-75497 (5 pages)
Docket Numbers:
Docket No. FDA-2024-N-4082
Topics:
Medical devices
PDF File:
2024-20999.pdf
CFR: (1)
21 CFR 876